Terrie Curran

Companies

• Arcutis Biotherapeutics, Inc.Board member Nov 4, 2020 to now¹
• Phathom Pharmaceuticals, Inc.Chief executive officer Jul 2, 2020 to Mar 3, 2025²
• Phathom Pharmaceuticals, Inc.President Jul 2, 2020 to Mar 3, 2025²
• Phathom Pharmaceuticals, Inc.Board member Oct 24, 2019 to Mar 3, 2025³
• Myovant Sciences Ltd.Board member Nov 17, 2016 to Mar 10, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPPhathom Pharmaceuticals, Inc. PHAT364,305 shares⁵$2.6M at $7.03Jan 23, 2025
• ABArcutis Biotherapeutics, Inc. ARQT23,526 shares⁶$764.6K at $32.50Aug 27, 2026
• MSMyovant Sciences Ltd.0 shares⁷Mar 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 27, 2026Sold 27,052 shares at $25.03 of Arcutis Biotherapeutics, Inc.⁶
• Aug 27, 2026Exercised options 27,052 shares at $8.63 of Arcutis Biotherapeutics, Inc.⁶
• Aug 27, 2026Sold 11,148 shares at $25.03 of Arcutis Biotherapeutics, Inc.⁶
• Aug 27, 2026Exercised options 11,148 shares at $7.51 of Arcutis Biotherapeutics, Inc.⁶
• Aug 20, 2026Sold 1,072 shares at $26.04 of Arcutis Biotherapeutics, Inc.⁸
• Aug 20, 2026Exercised options 1,072 shares at $7.51 of Arcutis Biotherapeutics, Inc.⁸
• Jun 5, 2026Granted 5,778 shares of Arcutis Biotherapeutics, Inc.⁹
• Jun 12, 2025Granted 7,609 shares of Arcutis Biotherapeutics, Inc.¹⁰
• Jan 21, 2025Sold 19,109 shares at $6.59 of Phathom Pharmaceuticals, Inc.⁵
• Nov 11, 2024Sold 8,687 shares at $10.85 of Arcutis Biotherapeutics, Inc.¹¹
• Jul 15, 2024Sold 33,848 shares at $11.72 of Phathom Pharmaceuticals, Inc.¹²
• Jun 14, 2024Granted 10,139 shares of Arcutis Biotherapeutics, Inc.¹³
• Mar 22, 2024Sold 16,851 shares at $9.11 of Phathom Pharmaceuticals, Inc.¹⁴
• Nov 1, 2023Granted 37,500 shares of Phathom Pharmaceuticals, Inc.¹⁵
• Jul 14, 2023Granted 200,000 shares of Phathom Pharmaceuticals, Inc.¹⁶
• May 31, 2023Granted 4,375 shares of Arcutis Biotherapeutics, Inc.¹⁷
• Apr 6, 2023Bought 12,919 shares at $7.82 of Phathom Pharmaceuticals, Inc.¹⁸
• Mar 10, 2023Returned to company 3,673 shares of Myovant Sciences Ltd.⁷
• Mar 1, 2023Sold 1,436 shares at $8.54 of Phathom Pharmaceuticals, Inc.¹⁹
• Jan 20, 2023Sold 5,821 shares at $8.20 of Phathom Pharmaceuticals, Inc.²⁰
• Jan 19, 2023Granted 97,500 shares of Phathom Pharmaceuticals, Inc.²⁰
• Nov 21, 2022Sold 1,526 shares at $9.60 of Phathom Pharmaceuticals, Inc.²¹
• Oct 26, 2022Granted 9,859 shares of Myovant Sciences Ltd.²²
• Sep 1, 2022Granted 7,500 shares of Phathom Pharmaceuticals, Inc.²³
• Jun 1, 2022Granted 4,312 shares of Arcutis Biotherapeutics, Inc.²⁴